Romanko Y S, Kaplan M A, Ivanov S A, Galkin V N, Molochkova Y V, Kuntsevich Z S, Tretiakova E I, Sukhova T E, Molochkov V A, Molochkov A V
Vopr Onkol. 2016;62(3):447-50.
The paper presented results of photodynamic therapy for 139 patients with basal cell carcinoma. We conducted a study of the efficacy and safety of four methods of photodynamic therapy. There were used the following photosensitizers: photohem, photosens, photolon and photodithazine. Photodynamic therapy using photosensitizers of chlorine series (photolon and photoditazin) provides a better long-term results improving disease-free 3-year survival rate to 90.4% and 92.3%, respectively compared to 54.7% and 71.1% in groups, in which treatment was restricted by photohem and photosens.
该论文展示了对139例基底细胞癌患者进行光动力治疗的结果。我们对四种光动力治疗方法的疗效和安全性进行了研究。使用了以下光敏剂：光血卟啉、光过敏素、光龙和光二嗪。与使用光血卟啉和光过敏素进行治疗的组相比，使用氯系光敏剂（光龙和光二嗪）的光动力治疗能带来更好的长期效果，将3年无病生存率分别提高到90.4%和92.3%，而前两组分别为54.7%和71.1%。
